期刊文献+

干细胞向胰岛素分泌细胞的定向分化及临床应用研究进展 被引量:1

Directional differentiation of stem cells into insulin producing cells and its clinical application
暂未订购
导出
摘要 糖尿病是危害人类健康的重大疾病之一,并呈高发态势。胰岛β细胞功能衰竭和胰岛素抵抗是糖尿病的主要病因,至今尚无根治良策。随着干细胞与再生医学技术的发展,利用干细胞的多向分化特性,诱导其分化为胰岛素分泌细胞,从而具备修复、替代受损胰腺组织的功能,这为糖尿病的彻底治愈带来了希望。现对近年来干细胞向胰岛素分泌细胞定向分化的研究及临床应用的最新研究进展进行综述,为干细胞移植治疗糖尿病的临床应用研究提供参考。 Diabetes mellitus is now a major disease that seriously endangers human health worldwide,and presents a high prevalence. Both the function failure of pancreatic β cells and insulin resistance are recognized as the primary mechanisms in the development of diabetes. Currently,there is no good strategy for cure. In recent years,considerable progress has been achieved in the fields of stem cell research and regenerative medicine. Stem cells with characteristic of multi-directional differentiation have been found to differentiate into insulin producing cells under a specific condition. It suggests that stem cells have the potential to restore and/or replace the lost cells in pancreatic tissue damaged,which bring hope of a cure for diabetics. The article precisely reviews the recent advances on differentiation of stem cells and its clinical application to provide support for the further clinical application of stem cell transplantation in the treatment of diabetes.
作者 罗熠 肖建辉 Luo Yi Xiao Jianhui(Institute of Medicinal Biotechnology,Affiliated Hospital of Zunyi Medical University,Zunyi Guizhou 563099,Chin)
出处 《合肥医学院学报》 2017年第4期446-452,共7页 Journal of Zunyi Medical University
基金 国家自然科学基金资助项目(NO:81460156 81660363) 贵州省高层次创新型人才培养计划(黔科合人才[2015]4028)
关键词 糖尿病 干细胞 胰岛素产生细胞 胰岛素 Diabetes mellitus stem cells insulin producing cells insulin
  • 相关文献

参考文献3

二级参考文献31

  • 1宋秀军,陈代雄,方宁,刘祖林,万卫红,刘金伟,章涛.人羊膜间充质细胞具有分化成软骨及成骨细胞的潜能[J].中国组织工程研究与临床康复,2007,11(50):10056-10060. 被引量:12
  • 2Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013,310(9) :948-959.
  • 3Brubaker PL, Drucker DJ. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system [ J ]. Endocrinology, 2004,145 ( 6 ) : 2653- 2659.
  • 4Davies M J, Kela R, Khunti K. Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes[ J]. Diabetes Obes Metab, 2011,13 (3) :207-220.
  • 5Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration [ J ]. Nat Biotechnol, 2003,21(7) :763-770.
  • 6Tsai PJ, Wang HS, Shyr YM, et al. Transplantation of insulin- producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats [ J ]. J Biomed Sci, 2012,19:47.
  • 7Si Y, Zhao Y, Hao H, et al. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity[ J]. Diabetes, 2012, 61 (6) :1616-1625.
  • 8Kempf K, Rose B, Herder C, et al. Inflammation in metabolic syndrome and type 2 diabetes : Impact of dietary glucose [ J ]. Ann N Y Acad Sci, 2006,1084:30-48.
  • 9Fiorina P, Jurewicz M, Augello A, et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes[ J]. J Immunol, 2009, 183 (2) :993-1004.
  • 10Madec AM, Mallone R, Afonso G, et al. Mesenchymal stem ceils protect NOD mice from diabetes by inducing regulatory T cells [ J ] Diabetologia, 2009,52 (7) : 1391-1399.

共引文献56

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部